Geode Capital Management LLC lessened its position in Envista Holdings Corporation (NYSE:NVST – Free Report) by 1.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 3,067,342 shares of the company’s stock after selling 38,952 shares during the quarter. Geode Capital Management LLC’s holdings in Envista were worth $66,606,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Jackson Creek Investment Advisors LLC acquired a new position in Envista during the fourth quarter valued at approximately $1,447,000. Royce & Associates LP boosted its position in Envista by 11.6% during the fourth quarter. Royce & Associates LP now owns 996,147 shares of the company’s stock valued at $21,626,000 after purchasing an additional 103,312 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in Envista by 64.4% during the fourth quarter. EverSource Wealth Advisors LLC now owns 4,223 shares of the company’s stock valued at $92,000 after purchasing an additional 1,654 shares during the last quarter. Global Retirement Partners LLC boosted its position in Envista by 51,028.6% during the fourth quarter. Global Retirement Partners LLC now owns 3,579 shares of the company’s stock valued at $78,000 after purchasing an additional 3,572 shares during the last quarter. Finally, IFP Advisors Inc boosted its position in Envista by 102.9% during the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after purchasing an additional 1,071 shares during the last quarter.
Wall Street Analyst Weigh In
Several brokerages recently commented on NVST. Morgan Stanley increased their price target on Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, April 24th. Citigroup began coverage on Envista in a research report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price target for the company. Robert W. Baird increased their price target on Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Barclays increased their price target on Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a research report on Wednesday, February 11th. Finally, Weiss Ratings cut Envista from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Six research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Envista currently has an average rating of “Hold” and a consensus price target of $28.83.
Envista Stock Performance
NVST opened at $23.45 on Tuesday. Envista Holdings Corporation has a 12-month low of $18.25 and a 12-month high of $30.42. The stock has a market cap of $3.82 billion, a price-to-earnings ratio of 57.20, a PEG ratio of 1.31 and a beta of 0.88. The business has a 50 day moving average of $25.08 and a 200-day moving average of $24.61. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47.
Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company had revenue of $705.50 million during the quarter, compared to analysts’ expectations of $680.04 million. During the same period last year, the firm posted $0.24 earnings per share. The business’s revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, equities research analysts expect that Envista Holdings Corporation will post 1.42 earnings per share for the current year.
Envista Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Further Reading
- Five stocks we like better than Envista
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
